skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Adjuvant imatinib not cost effective in GIST at high recurrence risk

PharmacoEconomics & outcomes news, 2019-01 (820), p.3-3

Copyright Springer Nature B.V. Jan 26, 2019 ;ISSN: 1173-5503 ;EISSN: 1179-2043

Full text available

Citations Cited by

Searching Remote Databases, Please Wait